Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Removal of Pertechnetate-Related Oxyanions from Solution Using Functionalized Hierarchical Porous Frameworks.

Banerjee D, Elsaidi SK, Aguila B, Li B, Kim D, Schweiger MJ, Kruger AA, Doonan CJ, Ma S, Thallapally PK.

Chemistry. 2016 Dec 5;22(49):17581-17584. doi: 10.1002/chem.201603908.

PMID:
27685610
2.

Zirconium-Based Metal-Organic Framework for Removal of Perrhenate from Water.

Banerjee D, Xu W, Nie Z, Johnson LE, Coghlan C, Sushko ML, Kim D, Schweiger MJ, Kruger AA, Doonan CJ, Thallapally PK.

Inorg Chem. 2016 Sep 6;55(17):8241-3. doi: 10.1021/acs.inorgchem.6b01004.

PMID:
27494264
3.

Computational Investigation of Technetium(IV) Incorporation into Inverse Spinels: Magnetite (Fe3O4) and Trevorite (NiFe2O4).

Smith FN, Um W, Taylor CD, Kim DS, Schweiger MJ, Kruger AA.

Environ Sci Technol. 2016 May 17;50(10):5216-24. doi: 10.1021/acs.est.6b00200.

PMID:
27049925
4.

Removal of TcO4(-) ions from solution: materials and future outlook.

Banerjee D, Kim D, Schweiger MJ, Kruger AA, Thallapally PK.

Chem Soc Rev. 2016 May 21;45(10):2724-39. doi: 10.1039/c5cs00330j.

PMID:
26947251
5.

Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions.

Halim SA, Clare RM, Newby LK, Lokhnygina Y, Schweiger MJ, Hof AW, Hochman JS, James SK, White HD, Widimsky P, Betriu A, Bode C, Giugliano RP, Harrington RA, Zeymer U.

Int J Cardiol. 2016 Jan 15;203:708-13. doi: 10.1016/j.ijcard.2015.11.036.

PMID:
26587725
6.

Temperature Distribution within a Cold Cap during Nuclear Waste Vitrification.

Dixon DR, Schweiger MJ, Riley BJ, Pokorny R, Hrma P.

Environ Sci Technol. 2015 Jul 21;49(14):8856-63. doi: 10.1021/acs.est.5b00931.

PMID:
26111202
7.

Does knowledge of the cost of cardiovascular tests influence physician ordering patterns?

Schweiger MJ, Giugliano GR, Cook JR, Mayforth J, Rothberg MB.

Hosp Pract (1995). 2014 Oct;42(4):46-52. doi: 10.3810/hp.2014.10.1141.

PMID:
25502128
8.

Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.

Hess CN, Schulte PJ, Newby LK, Steg PG, Dalby AJ, Schweiger MJ, Lewis BS, Armstrong PW, Califf RM, van de Werf F, Harrington RA.

Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):246-55. doi: 10.1177/2048872612474922.

9.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators..

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
10.

Rhenium solubility in borosilicate nuclear waste glass: implications for the processing and immobilization of technetium-99.

McCloy JS, Riley BJ, Goel A, Liezers M, Schweiger MJ, Rodriguez CP, Hrma P, Kim DS, Lukens WW, Kruger AA.

Environ Sci Technol. 2012 Nov 20;46(22):12616-22. doi: 10.1021/es302734y.

PMID:
23101883
11.

Bleeding risk and safety profile related to the use of eptifibatide: a current review.

Saab F, Ionescu C, Schweiger MJ.

Expert Opin Drug Saf. 2012 Mar;11(2):315-24. doi: 10.1517/14740338.2012.650164. Review.

PMID:
22233272
12.

Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.

Rothberg MB, Sivalingam SK, Ashraf J, Visintainer P, Joelson J, Kleppel R, Vallurupalli N, Schweiger MJ.

Ann Intern Med. 2010 Sep 7;153(5):307-13. doi: 10.7326/0003-4819-153-5-201009070-00005.

PMID:
20820040
13.

Door-to-balloon time: are we evaluating the wrong metric?

Peterman JM, George A, Giugliano GR, Schweiger MJ.

J Am Coll Cardiol. 2010 Jul 6;56(2):158-9. doi: 10.1016/j.jacc.2010.01.058. No abstract available.

14.

One can't judge a stent by its cover.

Giugliano GR, Schweiger MJ.

Arch Intern Med. 2010 May 24;170(10):915-6. doi: 10.1001/archinternmed.2010.145. No abstract available.

PMID:
20498422
15.

Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.

Stone GW, Martin JL, de Boer MJ, Margheri M, Bramucci E, Blankenship JC, Metzger DC, Gibbons RJ, Lindsay BS, Weiner BH, Lansky AJ, Krucoff MW, Fahy M, Boscardin WJ; AMIHOT-II Trial Investigators..

Circ Cardiovasc Interv. 2009 Oct;2(5):366-75. doi: 10.1161/CIRCINTERVENTIONS.108.840066.

16.

Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme.

Lasala JM, Cox DA, Lewis SJ, Tadros PN, Haas RC, Schweiger MJ, Chhabra A, Untereker WJ, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS.

EuroIntervention. 2009 May;5(1):67-77.

PMID:
19577985
17.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators., Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
18.
19.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators., Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317.

20.

Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry.

Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E.

Crit Pathw Cardiol. 2002 Mar;1(1):44-52.

PMID:
18340288
Items per page

Supplemental Content

Loading ...
Support Center